Simplex Trading, LLC Relmada Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 12,506 shares of RLMD stock, worth $35,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,506

Previous 41,270 69.7%

Holding current value

$35,016

Previous $123,000 67.48%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$2.3 - $4.36 $66,157 - $125,411	-28,764 Reduced 69.7%	12,506 $40,000
Q2 2024 Jul 25, 2024	SELL	$2.93 - $4.94 $15,947 - $26,888	-5,443 Reduced 11.65%	41,270 $123,000
Q1 2024 Apr 25, 2024	SELL	$3.1 - $6.8 $28,743 - $63,049	-9,272 Reduced 16.56%	46,713 $217,000
Q4 2023 Feb 02, 2024	BUY	$2.45 - $4.22 $43,276 - $74,542	17,664 Added 46.09%	55,985 $231,000
Q3 2023 Nov 01, 2023	SELL	$2.48 - $3.79 $14,984 - $22,899	-6,042 Reduced 13.62%	38,321 $114,000
Q2 2023 Aug 04, 2023	BUY	$2.22 - $3.54 $88,486 - $141,100	39,859 Added 884.97%	44,363 $109,000
Q1 2023 Apr 27, 2023	BUY	$2.24 - $4.76 $10,088 - $21,439	4,504 New	4,504 $10,000
Q1 2022 May 02, 2022	SELL	$16.72 - $26.99 $152,870 - $246,769	-9,143 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$16.93 - $26.82 $85,615 - $135,628	5,057 Added 123.76%	9,143 $205,000
Q3 2021 Oct 28, 2021	BUY	$21.86 - $34.77 $4,372 - $6,954	200 Added 5.15%	4,086 $137,000
Q2 2021 Aug 12, 2021	SELL	$29.55 - $39.15 $128,749 - $170,576	-4,357 Reduced 52.86%	3,886 $124,000
Q1 2021 Apr 26, 2021	BUY	$31.52 - $39.28 $259,819 - $323,785	8,243 New	8,243 $290,000
Q3 2020 Oct 14, 2020	SELL	$34.42 - $43.78 $30,220 - $38,438	-878 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$31.59 - $49.98 $11,151 - $17,642	353 Added 67.24%	878 $39,000
Q1 2020 Apr 29, 2020	SELL	$23.78 - $50.12 $38,404 - $80,943	-1,615 Reduced 75.47%	525 $17,000
Q4 2019 Feb 05, 2020	BUY	$10.1 - $47.18 $21,614 - $100,965	2,140 New	2,140 $83,000

Others Institutions Holding RLMD

# of Institutions

Shares Held

12.3M

Call Options Held

229K

Put Options Held

138K

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $80.1M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Relmada Therapeutics, Inc. Transaction History